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Abstract 
Caveolae are a specialized type of lipid rafts found in numerous cell types. These 
structures have been implicated as playing a role in a variety of metabolic regulation processes 
and are typically characterized by their association with the caveolin and cavin protein families. 
Caveolae are particularly enriched in adipocytes and here we analyze the effects of cavin 1 and 
cavin 2 knockdown in adipocyte functioning. We obtained several multiclonal mouse 3T3-L1 
cell lines with reduced expression of cavin 1 or cavin 2 by small interfering RNA approach 
using lentiviral vectors. We observed that cavin 1, but not cavin 2, depletion affects adipocyte 
differentiation and that both knockdown cells showed a reduced number of caveolae. We also 
verified that cavin 1 and cavin 2 expressions levels are dependent on each other and that both 
knockdowns caused a specific decrease in glucose transporter 4 (GLUT4) protein levels. 
Besides the lower protein levels of GLUT4, both knockdown cells also fail to translocate the 
transporter to the plasma membrane in response to insulin, although the insulin signaling 
pathway was not affected. As a consequence, knockdown cells show reduced insulin-stimulated 
glucose transport. Our results underscore the importance of cavin 1 and cavin 2 in glucose 
uptake and adipocyte metabolism. 
Keywords: Cavin 1; Cavin 2; GLUT4; Adipocytes;Caveolin-1;Caveolae 
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Resumo 
 Caveolas são um subtipo de lipid rafts presentes em diversos tipos celulares. Estas 
estruturas estão envolvidas em diversos processos de regulação metabólica e são tipicamente 
caracterizadas pela associação às famílias de proteínas, caveolinas e cavinas. As caveolas são 
particularmente abundantes em adipócitos e neste trabalho analisamos os efeitos do knockdown 
de cavina 1 ou cavina 2 no funcionamento de adipócitos. Foram obtidas várias linhas celulares 
3T3-L1 de rato, multiclonais, com reduzida expressão de cavina 1 ou cavina 2, utilizando RNA 
de interferência e vectores lentivíricos. Observámos que a redução proteica de cavina 1, mas não 
de cavina 2, afecta a diferenciação adipocitária e que ambos os knockdowns provocam uma 
redução  no número de caveolas. Também verificámos que os níveis de expressão de cavina 1 e 
cavina 2 são interdependentes e que o knockdown de cada uma das proteínas causa uma redução 
proteica do transportador de glucose 4 (GLUT4). Para além dos reduzidos níveis proteicos de 
GLUT4, ambas as linhas celulares knockdown não conseguem enviar este transportador para a 
membrana plasmática quando estimuladas por insulina, embora a cascata de sinalização por 
insulina não esteja afectada. Como consequência, as células knockdown apresentam um 
reduzido transporte de glucose em resposta a insulina. Os nossos resultados demonstram a 
importância de cavina 1 e cavina 2 na captação de glucose e no metabolismo de adipócitos. 
Palavras-chave: Cavina 1; Cavina 2; GLUT4; Adipócitos; Caveolina-1; Caveolas 
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1. Introduction 
1.1 Obesity and Type 2 Diabetes 
Obesity, defined as an abnormal or excessive fat accumulation that may impair health (World 
Health Organization, 2011a), is a condition that affects millions of people around the world, specially 
in western countries where the aggressive promotion of processed food, which commonly have high 
fat and carbohydrate content, coupled with reduction in caloric expenditure due to sedentary lifestyle 
is more evident (Friedman, 2002; Unger, 2003; Virally et al., 2007). 
Complications associated with obesity appear when adipose tissue exceeds its capacity to store 
lipids which results in deposition of these lipids in non-adipose tissues, such as pancreatic β-cells, 
liver, cardiac myocytes and skeletal muscle. In contrast to adipocytes, these tissues are poorly adapted 
to store lipids and this lipid deposition triggers lipotoxic disruption of cellular functions. Lipotoxicity, 
defined as lipid-induced dysfunction in non-adipose tissue, is of a central importance in the 
development of metabolic diseases such as Type 2 Diabetes (T2D), atherosclerosis, hypertension, etc 
(Blouin et al., 2008; Campbell, 2009; Costacou and Mayers-Davis, 2003; Friedman, 2002; Le Lay et 
al., 2009). 
In the last years, prevalence of T2D increased alarmingly, giving diabetes the dimension of an 
epidemic disease (Costacou and Mayers-Davis, 2003).  The disease comprises a complex and 
heterogeneous group of metabolic disorders often related with hyperglycemia (excessive hepatic 
glucose production and/or reduced glucose uptake), obesity and impaired insulin action (Friedman, 
2002; Guillausseau et al.,2008; Lin and Sun, 2010). Over time, diabetes can damage the heart, blood 
vessels, eyes, kidneys, and nerves. In the world, 346 million people have diabetes and T2D comprises 
90% of the cases (World Health Organization, 2011b) and it has also been estimated that from 1995 to 
the year 2025, the prevalence of diabetes will increase 42% among adults living in the developed 
world (Costacou and Mayers-Davis, 2003). Striking parallel increases in the prevalence of obesity 
reflect the importance of body fatness as a contributing factor to diabetes incidence. It is estimated that 
the risk of developing T2D is up to 75% in obese individuals (Costacou and Mayers-Davis, 2003; 
Virally et al., 2007). 
Improved understanding of the molecular mechanisms behind energy homeostasis might lead 
to effective strategies for the treatment of obesity and metabolic diseases. 
1.2 Adipocytes biology 
The adipose tissue is the body’s largest energy reservoir and so it is an important metabolic 
organ, crucial for whole-body insulin sensitivity and energy homeostasis. (Lafontan and Langin, 2009; 
Le Lay et al., 2009; Lefterova and Lazar, 2009; Unger, 2003) There are two types of adipose tissue, 
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the white adipose tissue (WAT) and brown adipose tissue (BAT). WAT, which is the predominant 
type of fat in adult humans, serves as a storage depot for excess energy, whereas BAT generates heat 
in newborns and rodents. (Lefterova and Lazar, 2009) 
Most energy reserves in the human body, lipids and glucose, are stored in fat cells as 
triacylglycerides (TAGs) and the adipose tissue is capable of exerting a buffer activity by increasing 
plasma TAG clearance and suppressing the release of free fatty acids (FFA) into circulation (Bickel et 
al., 2009; Ducharme and Bickel, 2008; Lafontan and Langin, 2009; Le Lay et al., 2009). In adipocytes 
(figure 1.1), TAGs arise from two major routes: de novo lipogenesis from non-lipid precursors (for 
example glucose) or uptake of FFA from plasma. In situations where energy is required (fasting and 
physical exercise) these TAGs are broken down to FFA and glycerol in a process called lipolysis 
(Lafontan and Langin, 2009; Le Lay et al., 2009). Glycerol and fatty acids are substracts for 
gluconeogenesis and ketogenesis, respectively, in liver. Skeletal muscle and heart use fatty acids for 
energy provision via mitochondrial β-oxidation and generation of ATP (Ducharme and Bickel, 2008). 
These metabolic processes (lipogenesis and lipolysis) are controlled by different stimulus 
being the most relevant, insulin and catecholamines (Bickel et al., 2009; Lafontan and Langin, 2009). 
 
 
 
 
 
 
 
 
 
1.2.1 Lipolysis regulation 
Adipocytes possess specialized structures, called Lipid Droplets (LDs), where the TAGs are 
stored. LDs contain a core of neutral lipids surrounded by a phospholipid monolayer and coated by 
Figure 1.1. Lipid metabolism in adipocytes. Lipogenesis and Lipolysis. FFA: free fatty acids; FABP: Fatty acid 
binding protein; FATP: Fatty acid transport proteins; CD36: Fatty acid translocase; ACS: Acyl-CoA synthetase; 
LPL: Lipoprotein lipase; TAG: triacylglyceride. (Adapted from González-Muñoz, 2007). 
3 
 
specific proteins such as perilipin, a member of the PAT protein family. The protein content of the 
LDs can vary within droplets of the same cell and between cell types (Bickel et al., 2009). 
Perilipin was the first member of the termed “PAT family” and in mice and humans a single 
perilipin gene gives rise to 3 isoforms of the protein (with approximately 55 kDa), by alternative 
splicing. Perilipin A (56,8 kDa) is the most abundant isoform and the focus of all functional studies 
(Bickel et al., 2009; Brown, 2001; Forcheron et al., 2005). 
Perilipin has a major role in regulating the accessibility to the TAGs stored in the LDs. This 
protein can either restrict LD accessibility of enzymes that hydrolyze lipid esters (lipases) or facilitate 
their enzymatic activity under appropriate metabolic conditions. In adipocytes, in the lipolytic 
pathway, catecholamines signal through a β-adrenergic receptor and G-protein coupled signaling 
cascade to elevate cellular cAMP levels. This in turn activates cAMP-dependent Protein Kinase A, 
which phosphorylates perilipins and hormone sensitive lipase (HSL). HSL then translocates from 
cytoplasm to the LDs surface and the access to TAG is facilitated by the phosphorylated perilipins. 
(Lafontan and Langin, 2009; Bickel et al., 2009; Ducharme and Bickel, 2008). 
Recently another lipase, adipocyte triglyceride lipase (ATGL) has emerged as the major TAG 
Lipase. ATGL catalyzes the initial step in lipolysis (hydrolysis of TAG to Diacylglyceride, DAG), 
while HSL catalysis the second step (hydrolysis of DAG to Monoacylglyceride, MAG). Finally a 
soluble monoglyceride lipase catalyzes the breakdown of MAG to glycerol and FFA. In contrast to 
HSL, ATGL appears to reside on the LD surface and to be independent of Protein Kinase A activation. 
Glycerol is used as a gluconeogenic substract in the liver and FFA as a source of energy in the liver, 
skeletal muscle and heart (Bickel et al., 2009; Brown, 2001; Ducharme and Bickel, 2008). 
1.3 Insulin action and glucose transport 
Adipose tissue plays a critical role in energy homeostasis in higher organisms. It is able to 
remove glucose and TAGs from plasma and store it inside special structures called LDs and so 
avoiding fatty acids accumulation in other organs where it could trigger lipotoxic disruption of cellular 
functions (Blouin et al., 2008; Le Lay et al., 2009). In both muscle and fat cells, insulin stimulates the 
translocation of the Glucose Transporter Type 4 (GLUT4) (main glucose transporter in these cells) 
from an intracellular location to the cell surface, where it facilitates the reduction of plasma glucose 
levels (Bryant et al., 2002).  
Understanding the molecular mechanisms that mediate this translocation event involves 
integrating our knowledge of two fundamental processes — the signal transduction pathways that are 
triggered when insulin binds to its receptor and the membrane trafficking events that need to be 
modified to divert GLUT4 from intracellular storage to the plasma membrane. 
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1.3.1 Insulin biology 
Insulin is a peptidic anabolic hormone, composed of 51 a.a. and with a molecular weight of 
5808Da. It is a small protein made of two polypeptide chains and exerts its function through biding to 
its receptors located in many cell types. Insulin is produced in β-pancreatic cells and has a central role 
in cellular metabolism and in lowering blood glucose concentration (Aronoff et al., 2004).  
In order to reduce the glucose concentration in the blood, insulin-sensitive tissues, like adipose 
tissue and skeletal muscle, increase glucose uptake upon insulin binding through recruitment of 
GLUT4 to the plasma membrane. Insulin also inhibits pancreatic α-cells glucagon production, which 
leads to the inhibition of hepatic gluconeogenesis and glycogenolysis (Aronoff et al., 2004; González-
Muñoz, 2007; Klip, 2009; Young, 2005). 
Insulin is also important in the cellular metabolism of adipocytes. It promotes adipocytes 
differentiation, uptake not only of glucose but also of FFA, lipoprotein lipase activity, synthesis of 
TAG from both glucose (de novo lipogenesis) and from FFA (lipogenesis) and inhibition of lipolysis 
of TAGs stored in LD (González-Muñoz, 2007). 
The failure of insulin to stimulate glucose uptake and storage appears to be a primary defect 
already detectable at the initial stages of insulin resistance (DeFronzo and Tripathy, 2009; Lamb et al., 
2010; Vollenweider et al., 2002). 
1.3.2 Insulin signaling pathway 
 The most accepted insulin signaling pathway that leads to the translocation of GLUT4 to the 
membrane is the Phosphatidylinositol 3-Kinase (PI3K) dependent pathway (figure 1.2) (Farese, 2002; 
Welsh et al., 2005). This insulin pathway involves a cascade of events initiated by insulin binding to 
its cell surface receptor (IR). Following insulin biding to IR it becomes activated by 
autophosphorylation and phosphorylates tyrosines in the Insulin Receptor Substrate 1 (IRS-1). The 
tyrosines act as a docking site for the Scr Homology 2 (SH2) domain that exists in the p85 subunit of 
PI3K and IRS-1 activates PI3K. Following PI3K activation there is a production of lipidic second 
messengers, like Phosphatidylinositol-3,4,5-triphosphate (PIP3), which leads to the stimulation of 
downstream proteins including Protein Kinase B (PKB or Akt) and Protein Kinase C Zeta (PKC ζ). 
Akt phosphorylates the Rab GTPase activating protein (Akt Substrate 160kDa (AS160)), which in turn 
is inhibited, allowing the stabilization of Rab proteins that together with PKC ζ lead to the 
translocation of GLUT4 from intracellular vesicles to the plasma membrane (Choi and Kim, 2010; 
González-Muñoz, 2007; Rowland et al., 2011; Watson and Pessin, 2006). 
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1.3.2.1 Insulin receptor 
 The IR belongs to a family of cell-surface receptors that possess intrinsic tyrosine kinase 
activity (Huang and Chen, 2009). IR is composed of two extracellular α and two transmembrane β 
subunits disulfide-linked into an α2β2 heterotetrameric structures (González-Muñoz, 2007; Watson 
and Pessin, 2001). Upon insulin binding to the α-subunits, a transmembrane conformational change is 
generated that activates the intracellular subunit tyrosine kinase domain. The β-subunit undergoes a 
series of intramolecular autophosphorylations, activating them. After this, IR is able to phosphorylate 
the subsequent insulin signaling cascade proteins like the IRS-1 (Choi and Kim, 2010; González-
Muñoz, 2007; Watson and Pessin, 2001; Zaid et al., 2008). 
1.3.2.2 Insulin Receptor Subtract 
 IRS-1 is a key mediator in the insulin signaling cascade. IRS family members contain a NH2-
terminal Pleckstrin Homology (PH) domain that binds to membrane phospholipids, an adjacent 
phosphotyrosine-binding domain and a variable length C-terminal tail that contains a number of 
tyrosine and serine phosphorylation sites (Boura-Halfon and Zick, 2009; Zaid et al., 2008). Several of 
these phosphorylation sites are located in amino acid sequence motifs that bind to SH2 domain 
proteins (Sesti et al., 2001; Zaid et al., 2008). 
 
Figure 1.2. The insulin signaling pathway. Akt: protein kinase B; AS160: Akt 160KDa substrate; GLUT4: 
glucose transporter 4; IRS-1: insulin receptor substrate-1; PDK: phosphoinositide-dependent kinase; PKC ζ: 
protein kinase C zeta; PH: pleckstrin homology domain; PI3K: phosphoinositide 3-kinase (regulatory subunit 
p85 and catalytic subunit p110); PIP: phosphatidylinositol phosphate. (Adapted from Choi and Kim, 2010). 
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1.3.2.3 Phosphatidylinositol 3-kinase  
PI3K is a heterodimeric lipid kinase, with a regulatory (85KDa) and a catalytic subunit 
(110KDa), with four isoforms (α, β, γ and δ), according to catalytic subunit differences, and plays an 
essential role in glucose uptake and GLUT4 translocation (González-Muñoz, 2007; Huang and Chen, 
2009; Zaid et al., 2008). 
In a basal situation (without insulin) PI3K is in the cytosol, in the presence of insulin the p85 
subunit interacts with phosphorylated IRS-1 through SH2 domain (present in p85 subunit) and brings 
p110 subunit closer to the membrane. This proximity allows p110 to phosphorylate membrane 
phospholipids and Phosphatidylinositol 4,5-biphosphate on the 3’ position, catalyzing the formation of 
PIP3. PIP3 is able to stimulate the activity of Phosphoinositide-Dependent Kinases (PKD-1 and PKD-
2) which initiates the activation of its downstream effectors, Akt and PKC ζ (González-Muñoz, 2007; 
Choi and Kim, 2010; Watson and Pessin, 2001). 
1.3.2.4 Akt (or PKB) 
The serine/threonine protein kinase Akt plays important roles in several signaling cascades 
(Liao and Hung, 2010). Akt has 3 different isoforms, Akt1/PKBα, Akt2/PKBβ and Akt3/PKBγ, which 
have distinct tasks in cell survival, growth and metabolism (Bellacosa et al., 2004).  Akt2 is primarily 
important for glucose homeostasis by being a signaling molecule in the insulin signaling cascade. 
Each Akt isoform possess an N-terminal PH domain, which allows Akt to bind PIP3, a C-
terminal regulatory domain containing a hydrophobic motif and a central kinase domain (Bellacosa et 
al., 2004). Akt is able to bind to the PI3K products (PIP3) and this union has a double action. First it 
moves Akt from the cytosol to the membrane, closer to both PKDs, second it induces conformational 
changes in Akt that make its phosphorylation by PKD-1 (Thr308) and PKD-2 (Ser473) possible (Choi 
and Kim, 2010;Rowland et al., 2011; Watson and Pessin, 2001). When phosphorylated, Akt is fully 
activated. 
1.3.2.5 Protein Kinase C zeta 
PKC ζ is a member of the PKC serine-threonine family, that acts downstream of PI3K. The 
PKC family plays important roles in many intracellular signaling events, cell growth and 
differentiation (Sampson and Cooper, 2006).  
In the absence of insulin, PKC ζ was described to be a negative regulator of Akt (Dandekar et 
al., 1998; Doornbos et al., 1999) while in the presence of insulin, PKC ζ becomes activated and 
enables Akt activity and GLUT4 translocation. Not only insulin but also glucose and exercise can 
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activate PKC ζ through diverse pathways. For that, PKC ζ activation and activity are impaired in 
insulin resistance in muscle and adipose tissues of type II diabetic individuals (Liu et al., 2006). 
1.3.3 GLUT4 
Facilitated glucose transporters family is characterized by 12 transmembrane domains that 
allow all the isoforms to catalyze hexose transport across the cell through an ATP-independent 
facilitative diffusion mechanism (Huang and Czech, 2007). 
Adipocytes express Glucose Transporter Type 1 (GLUT1) and GLUT4. GLUT1 presents a 
ubiquitous expression and is responsible for the basal glucose transport in these cells. GLUT4 is 
responsible for the insulin-stimulated glucose transport in adipocytes, skeletal muscle and heart 
(González-Muñoz, 2007; Watson and Pessin, 2001). 
In contrast to the other GLUT isoforms, which are primarily localized to the plasma 
membrane in the absence of insulin, GLUT4 transporter proteins are retained into specialized storage 
vesicles connected to the endosomal-trans Golgi network system, called Glucose Transporter Isoform 
4 Storage Vesicle (GSVs) (Klip, 2009; Lamb et al., 2010; Watson et al., 2004; Williams et al., 2006; 
Zaid et al., 2008). 
In unstimulated muscle or adipocytes (absence of insulin), 4-10% of GLUT4 is located at the 
cell surface and >90% at intracellular compartments (GSVs). This steady-state distribution of GLUT4 
is the balance of its fast endocytosis and slow exocytosis (Bryant, 2002; Lamb, 2007; Zaid et al., 
2008). 
In the presence of insulin, the hormone initiates the insulin-signaling cascade which leads to 
the accumulation of GLUT4 at the plasma membrane (approximately 55% in specialized structures 
called caveolae) (Ros-Baró et al., 2001; Karlsson et al., 2002) by increasing exocytosis and modestly 
decreasing the endocytosis rate of the GSVs (Bryant et al., 2002; Klip, 2009; Zaid et al., 2008). 
So that the increase in exocytosis occurs it is necessary that the substrate of Akt, the AS160 is 
phosphorylated. AS160 is phosphorylated and inhibited both Akt, and is involved in the regulation of 
several membrane transport steps, including vesicle budding, motility, tethering and fusion (Choi and 
Kim, 2010; González-Muñoz, 2007; Rowland et al., 2011; Watson and Pessin, 2006). The 
consequence of such inhibition is the stabilization of the AS160 target Rab proteins in the GTP-bound 
form, which is thought to promote vesicle trafficking (Klip, 2009; Rowland et al., 2011; Watson and 
Pessin, 2006). 
1.4 Caveolae 
Lipid rafts are lateral assemblies of sphingolipids and cholesterol that form a separate liquid-
ordered phase in the liquid disordered matrix of the lipid bilayer. Lipid rafts function as platforms with 
which distinct classes of proteins are associated, such as glycosylphosphatidylinositol-anchored 
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proteins, transmembrane proteins, and diacylated proteins (Lajoie and Nabi, 2010; Ros-Baró et al., 
2001).  
Caveolae, morphologically described in the early 1950s, are a specialized type of lipid raft that 
appear in the plasma membrane (Briand et al., 2010; González-Muñoz et al., 2009; Parton et al., 
2006). These membrane strutures were first identified by electron microscopy and were defined as 
flask-shaped invaginations with 50-100nm of diameter (Chadda and Mayor, 2008; Hansen and 
Nichols, 2010; Liu et al., 2008). Caveolae function has been widely debated and has been implicated 
in membrane trafficking, signal transduction, substrate transport, endocytosis and cancer (Briand et 
al., 2010; Hayer et al., 2010; Hansen and Nichols, 2010). These structures have also been exploited by 
pathogens, both as direct portals for endocytic entry and to facilitate the entry of pathogens that are 
larger than a single caveolae (Parton and Simons, 2007). Caveolae are present in many cell types like 
muscle cells, endothelian cells, but are particularly abundant in adipocytes, where they account for 
30% of the plasma membrane surface and recently caveolae were defined as indispensable structures 
in the protection of fat cells against lipotoxic effects of elevated levels of fatty acids (Meshulam et al., 
2011). 
IR and GLUT4 are two important molecules in the mechanism of removing glucose from 
blood in response to insulin, as described in section 1.3. In adipocytes IR and GLUT4, when in the 
membrane, are localized in caveolae and it has been shown that in the absence of these structures, the 
levels of IR and GLUT4 are decreased (González-Muñoz et al., 2009; Meshulam et al.,2011). Thereby 
caveolar formation and stability is critical to the adipocytes metabolism. Caveolae have two major 
protein components, caveolins and cavins (González-Muñoz et al., 2009). 
1.4.1 Caveolins 
Caveolins are the major coat constituent of caveolae. Caveolins family comprises caveolin-1, 
the main and most widespread caveolin, caveolin-2, expressed in the same cells that caveolin-1, and 
caveolin-3 expressed exclusively in muscle cells (Hansen and Nichols, 2010; Hill et al., 2008; Parton 
et al., 2006). The 3 isoforms have molecular weights between  15 and 20 kDa and all of them are 
multiply acylated proteins embedded in the cytosolic leaflet of cell membrane (never reaching the 
outside of the cell), with both N- and C-termini residing in the cytosol (figure 1.3) (González-Muñoz, 
2007; Hansen and Nichols, 2010; Liu and Pilch, 2008). 
Caveolins are able to form oligomers and act as scaffolding proteins that bind and concentrate 
cholesterol. It is estimated that caveolin-1 forms oligomers of 14-16 monomers and that each caveolae 
has around 144 caveolin molecules (González-Muñoz, 2007; Hansen and Nichols, 2010; Hill et al., 
2008). In addition to their structural role, caveolins are also involved in endocytosis/transcytosis and 
cholesterol/lipid trafficking. Moreover, caveolins can also segregate signal initiation events by 
concentrating and organizing signaling molecules (González-Muñoz et al., 2009; Hansen and Nichols, 
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2010; Hill et al., 2008). Besides its presence and role within caveolae, caveolin-1 has also been 
identified in LDs (Blouin et al., 2008). Although its role in LDs is unclear, it has been observed that 
caveolin-1 concentration on adipocyte LD positively correlated with LD size in obese rodent models 
and human adipocytes (Blouin et al., 2010). Moreover caveolin-1 null mice exhibit markedly 
attenuated lipolytic activity (Cohen et al., 2004; Meshulam et al.,2011). Caveolins have also been 
strongly linked to breast and prostate cancer (Engelman et al., 1998; Tahir et al., 2008) and, in the 
case of muscle-specific caveolin-3, to muscle diseases known as muscular caveolinopathies (Bastiani 
et al., 2009). 
Caveolin-1 expression, and caveolin-3 in muscle cells, is necessary for caveolae formation 
(Hayer et al., 2010; Liu et al., 2008; Parton et al., 2006). It has been shown that the lack of caveolin-1 
and caveolin-3 results in absence of caveolae and that these structures are restored upon caveolin-1 or 
-3 expression (Hansen and Nichols, 2010). By contrast, loss of caveolin-2, which is generally 
expressed together with caveolin-1, does not affect the formation of caveolae (Hansen and Nichols, 
2010; Hayer et al., 2010; Parton et al., 2006).  
 
 
 
 
 
 
 
 
1.4.2 Cavins 
Cavins are another essential caveolae component (figure 1.4) (Hansen and Nichols, 2010; Hill 
et al., 2008; Liu et al., 2008). This family comprises 4 isoforms, polymerase I and transcript release 
factor (PTRF or cavin 1); serum deprivation protein response (SDPR, SDR or cavin 2); SDR related 
gene product that binds to protein C-kinase (SRBC or cavin 3) and muscle restricted coiled-coil 
protein (MURC or cavin 4) (Briand et al., 2010; Hayer et al., 2010).  
Cavin 1 to 3 family members display the same pattern of expression as caveolin-1whereas 
cavin 4 expression parallels that of caveolin-3 (Bastiani et al., 2009; Liu et al., 2008). All of them 
Figure 1.3. Caveolin-1structure and disposition in caveolae. Caveolin is inserted into the caveolar membrane, 
with the N and C termini facing the cytoplasm and a putative ‘hairpin’ intramembrane domain embedded within 
the membrane bilayer. The scaffolding domain, a highly conserved region of caveolin, might have a role in 
cholesterol interactions through conserved basic (+) and bulky hydrophobic residues (red circles). The C-
terminal domain, contains three cysteine residues modified by palmitoyl groups. (Adapted from Parton and 
Simons, 2007) 
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have been shown to be present in caveolae and to show similar features in terms of molecular 
organization (Briand et al., 2010; Hansen and Nichols, 2010). Indeed, they all contain putative leucine 
zippers-like domains normally involved in protein-protein interations and, excepting cavin 4, PEST 
domains (regions rich in proline (P), glutamic acid (E), serine (S), and threonine (T)). Another 
common feature between cavins is their ability to bind phosphatidylserine and to be phosphorylated in 
multiple sites (Briand et al., 2010; Hayer et al., 2010). 
Several studies have shown that an important aspect of the biology of cavins is their ability to 
form complexes with each other (cavins can form complexes even in the absence of caveolin proteins) 
(Briand et al., 2010; Hayer et al., 2010). The fact that cavins show tissue-specific expression profiles 
implies that the cavin complexes associated with caveolae are different in different tissues and the 
stoichiometry between cavins could determine the functionality of caveolae (Bastiani et al., 2009; 
Briand et al., 2010; Nabi, 2009). Therefore, cavins are of extreme importance in the correct function 
of caveolae. 
1.4.2.1 Cavin 1 
Cavin 1 was originally identified as a soluble nuclear factor that regulates transcription, it was 
only recently that this factor was abundantly found in the cytoplasmic face of caveolae, leading cavin 
1 to be consider a caveolae marker (Briand et al., 2010; Hill et al., 2008; Vinten et al., 2005). 
Cavin 1 is located to caveolae in both muscle and non-muscle tissues, having in this manner a 
tissue distribution broader than that of either caveolin-1 or caveolin-3 (Hansen and Nichols, 2010). In 
non-muscle tissues, cavin 1 expression was found to be strictly parallel to that of caveolin-1, it is 
estimated that cavin 1 and caveolin-1 are present in a 1:1 ration within caveolae (Chadda and Mayor, 
2008; Hill et al., 2008). 
Previous experiments revealed that cavin 1 downregulation results in a reduction of cavin 2 
and cavin 3 expression levels and in an increase of caveolin-1 mobility, which is released from the cell 
surface and rapidly internalized and degraded (Bastiani et al., 2009; Chadda and Mayor, 2008; Hill et 
al., 2008), as a result the absence of cavin 1 leads to the loss of morphologically identifiable caveolae 
(Briand et al., 2010; Hill et al., 2008; Nabi, 2009). Moreover experimental results tend to prove that 
cavin 1 is specially important to the last steps of caveolae biogenesis (figure 1.4) (Chadda and Mayor, 
2008; Hill et al., 2008; Liu and Pilch, 2008). Indeed, cavin1 only associates with plasma membrane 
caveolin but not with non-caveolar caveolins (like caveolins at the Golgi apparatus) (Hansen and 
Nichols, 2010; Hayer et al., 2010). Therefore, cavin 1 has to be considered as a soluble protein which 
would be recruited to caveolae, operating like a new scaffold stabilizing the caveolae unit (Briand et 
al., 2010). Not only cavin 1 is necessary for caveolae formation but it has also been suggested that 
cavin 1 is required to recruit cavin complexes to caveolae (Bastiani et al., 2009). Besides caveolae 
localization, cavin 1 has also been found in the membrane of LDs in association with caveolin-1 and to 
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be implicated in lipolysis regulation together with HSL (Aboulaich et al., 2006). It has also been 
demonstrated that mice lacking cavin 1 present a higher circulating TAG levels, reduced adipose 
tissue, glucose intolerance, hyperinsulinemia, all consistent with a lipodystrophic phenotype (Liu et 
al., 2008) 
1.4.2.2 Cavin 2 
Cavin 2 shares more than 20% similarities with cavin 1 (Briand, 2010; Hansen, 2009). This 
second member of the cavin family was found to be enriched in caveolae and to co-localize with 
caveolin-1 and cavin 1 (Briand, 2010; Hansen et al., 2009; Hansen and Nichols, 2010). It has been 
shown that cavin 2 is able to bind cavin 1, independently of caveolin-1, and recruit it to caveolae 
(Briand et al., 2010; Hansen et al., 2009). Experimental results have shown that cavin 2 
downregulation induces loss of cavin 1 and caveolin-1 expression and therefore limits caveolae 
formation and even if caveolin-1 and cavin 1 are overexpressed, cavin 2 downregulation still reduces 
caveolae formation (Briand, 2010; Hansen et al., 2009; Hansen and Nichols, 2010; Nabi, 2009). 
Thereby, cavin 1, cavin 2 and caveolin-1 are functionally interdependent. An interesting observations 
is that, unlike cavin 1 and caveolin-1, overexpression of cavin 2 alone does not increase caveolae 
number instead induces changes in caveolae morphology, which turns to appear larger and induces 
caveolae-associated tubule formation (Briand et al., 2010; Hansen et al., 2009; Nabi, 2009). Therefore, 
cavin 2 could be seen as the membrane curvature-inducing component of caveolae (figure 1.4). 
1.4.2.3 Cavin 3 
Considering its homology with cavin 1, a role in caveolae structure has been considered, 
however it is still not clear whether cavin 3 is directly required for caveolae morphogenesis or not 
(Hansen and Nichols, 2010), but it has been shown that cavin 3 associates with caveolin-1 and that it is 
able to regulate caveolae endocytosis (figure 1.4) (Hayer et al., 2010; Nabi, 2009). In contrast with 
cavin 1 and cavin 2, cavin 3 knockdown (KD) does not affect caveolin-1 levels, however it limits 
budding and intracellular trafficking of caveolin-1-positive vesicles from the plasma membrane 
(Briand et al., 2010; McMahon et al., 2009; Nabi, 2009). 
Apart from the role in adipocytes, it has been shown that the human CAVIN3 gene is situated 
in a tumor suppressor region and is inactivated in breast and lung cancer (Briand et al., 2010). 
1.4.2.4 Cavin 4 
Cavin 4 is a muscle-specific protein (expression pattern parallels that of caveolin-3), 
previously described as purely cytosolic and able to interact with cavin 2 (Bastiani et al., 2009; Briand 
et al., 2010; Hansen and Nichols, 2010; Liu et al., 2008; Nabi, 2009). Cavin 4 distribution is perturbed 
in human muscle disease associated with caveolin-3 dysfunction, identifying cavin 4 as a novel muscle 
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disease candidate caveolar protein (Bastiani et al., 2009). Over expression of this protein in the heart is 
sufficient to induce cardiac contractile dysfunction (Hansen and Nichols, 2010). In contrast with cavin 
2 and cavin 3, cavin 4 expression levels are not affected by the absence of cavin 1 (Bastiani et al., 
2009). 
 
 
 
 
 
 
 
 
 
 
 
1.5 Objectives 
It has recently been shown that cavins are essential caveolar components and that cavins and 
caveolins, other major caveolar proteins, are interdependent (Hill et al., 2008, Vinten et al., 2005).  In 
vivo studies revealed that cavin 1 knockout (KO) mice lack caveolae, are insulin resistant and present 
a lipodystrophic phenotype (Liu et al., 2008) and indeed, recently published data identified cavin 1 as 
a locus for human lipodystrophy (Garg, 2011; Hayashi et al., 2009). Studies in cavin 2 KD cells have 
also revealed that cavin 2 is essential for cavin 1 recruitment to the caveolae and that cavin 2 acts as 
the caveolae membrane curvature-inducing component (Hansen et al., 2009). 
Figure 1.4. Regulation of caveolae morphology and dynamics by cavin family members. Recent data revealed 
the existence a multimeric protein complex containing all cavin members, which associate with caveolins at the 
plasma membrane. Individual overexpression or downregulation of each cavin member has an effect on 
biogenesis, morphology or dynamics of the caveolae structures. Cavin 1 is recruited by caveolins to plasma 
membrane caveolar domains and is required for caveolae formation. Cavin 2 alone does not increase caveolae 
number but induces changes in caveolae morphology, which turns to appear distended. Cavin 3 still associates 
with caveolin upon caveolae budding to form vesicles and its absence markedly impairs intracellular caveolin-1 
traffic along microtubules. Cavin 4, which has an expression restricted to cardiac and muscle tissues (parallel 
that of caveolin-3), constitutes the muscle-specific component of the cavin complex and associates with muscle-
caveolae. (Adapted from Briand, 2010). 
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Considering the importance of caveolae in the proper functioning of adipocytes and knowing 
that cavin 1 and cavin 2 are essential caveolar proteins we decided to study the role of cavin 1 and 
cavin 2 in adipocyte function. To do so, we obtained 3T3-L1 cell lines with a reduced expression of 
cavin 1 or cavin 2 by a small interfering RNA (siRNA) strategy. We analyzed the differentiation 
capability, caveolae morphology, insulin-mediated glucose uptake and insulin signaling cascade in 
these KD cell lines. 
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2. Materials and Methods 
 
2.1 Entities 
This work was carried out at the Department of Biochemistry and Molecular Biology, Faculty 
of Biology, University of Barcelona (FB/UB) and at the Institute for Research in Biomedicine, Parc 
Científic of Barcelona (IRB,Barcelona/PCB). 
 
2.2 Materials  
Table 2.1 - List of reagents and materials used in this work and respective references. 
Products References 
2-deoxy[H3]-glucose American Radiolabeled, cat#ART-103A 
2-deoxyglucose Sigma, cat#D8375 
D-(+)-glucose Sigma, cat#G8270 
Acrylamide solution (30%) National Diagnostics,cat#EC-890 
Aprotinin Sigma, cat#A6279 
APS BioRad,cat#161-0700 
Broad range molecular weight (pre-stained) BioRad cat#161-0318 
Bromophenol blue BioRad,cat#161-0404 
BSA- Fatty acid free Sigma, cat#A6003 
CS BioWhittaker 14-401F 
Dexamethasone-water soluble Sigma, cat#D2915 
DMEM Gibco,cat#41966-052 
DMSO Sigma, cat#D2650 
EDTA Calbiochem, cat#324503 
FBS Gibco, cat#10270-106 
Glycine Roche, cat#03117251001 
Glycerol Sigma, cat#G5516 
HEPES Sigma, cat#H3375 
Hydrogen Peroxide Sigma, cat#H1009 
IBMX Sigma, cat#I-7018 
Insulin Human Lilly, cat#KG5-WEF-179 
Igepal CA630 Sigma, cat#I8896 
Isopropanol Panreac, cat#141090 
Leupeptin Sigma, cat#L2884 
Luminol Fluka, cat#09253 
Methanol Panreac, cat#141091 
Mini-Protean® System III Biorad 
Mini-Protean® TransBlot Cell System Biorad 
Oil Red O Sigma, cat#O-0625 
p-Coumaric acid Fluka, cat#2820 
Paraformaldehyde Fluka, cat#76240 
Penicillin-Streptomycin Gibco,cat#15140-163 
Pepstatin  Sigma, cat#A5318 
Radiographic films Fujifilm, cat#4741008389 
Pierce® BCA Protein Assay Reagent Thermo Scientific, cat#23225 
PMSF Merck, cat#1,07349,0005 
Poly-L-Lysine Sigma, cat#P1524 
PEI Polysciences Inc., cat#23966 
ProLong® Gold antifade reagent Invitrogen, cat#P36930 
Protein G-sepharose beads Sigma, cat#P3296 
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Puromycin dihydrochloride solution Sigma, cat#P9620 
PVDF Membrane ImmobilonTM-P; Millipore, #IPVH00010 
Rosiglitazone SmithKline Beecham 
Scintillation liquid Ecolite, cat#882475 
SDS Panreac, cat# 142363 
Sodium deoxycholate Sigma, cat#D6750-25G 
Sodium pyruvate Sigma, cat#P2256 
Sucrose Sigma, cat#S9378 
TEMED Biorad,cat#161-0801 
Triglycerides assay kit BioSystems, cat#11528 
Triton-X-100 Merck, cat#8603 
Tris-base Panreac, cat#141940 
Tween-20 Sigma, cat#P1379 
Trypsin Invitrogen, cat#25300-062 
Ultracentrifuge tubes Beckman Coulter, cat#358126 
 
2.2.1 Antibodies 
Table 2.2 - Primary antibodies used in this work for Western blot (WB), Immunoprecipitation (IP) 
and Immunolocalization(IL). 
Target Supplier Raised in 
MW 
(kDa) 
Used for 
WB IP IL 
β-actin Sigma cat# AC-15 Mouse 45 1:10000   
Cavin-1 Suplied by Dr.Paul Pilch Rabbit 60 1:1000  1:200 
Cavin-2 Suplied by Dr.Paul Pilch Rabbit 68 1:1000  1:200 
Caveolin-1 Transduction laboratories Rabbit 22 1:1000  1:200 
GLUT4 Generated in our laboratory Rabbit 55 1:1000  1:200 
Perilipin Upstate Biotech, Cat#AB10200 Rabbit 64 1:1000  1:200 
Akt Cell signaling, Cat#9272 Rabbit 60 1:1000   
InsR β-chain (4B8) Cell signaling, Cat#3025 Rabbit 95 1:500   
PI3K (p85 subunit) Upstate Biotech, Cat#06-195 Rabbit 85 1:1000   
IRS-1 Cell signaling, Cat#2382 Rabbit 180 1:500 3µL/500µg  
Phospho-Tyr residues Upstate Biotech, Cat#05-321 Mouse - 1:1000 3µL/500µg  
Phospho-Akt (Ser473) Cell signaling, Cat#9271 Rabbit 60 1:1000   
ATGL Cell signaling, Cat#2138 Rabbit 54 1:1000   
FABP4 Cell signaling, Cat#2120S Rabbit 15 1:1000   
 
 
 
Table 2.3 - Secondary antibodies used in this work for Western blot (WB), Immunofluorescence (IF) 
and Freeze Drying (FD). 
 
 
 
 
 
Antibody 
description Supplier 
Used for 
WB IF FD 
Goat Anti-Rabbit 
IgG (H+L) 
Jackson Immuno Research  
711-035-152 1:10000   
Donkey Anti-
Mouse  IgG (H+L) 
Jackson Immuno Research 
715-035-150 1:10000   
Donkey Anti-
Rabbit  IgG (H+L) 
Jackson Immuno Research 
711-165-152  1:200  
Goat Anti-Rabbit 
IgG (H+L) 
Jackson Immuno Research 
111-205-144   1:30 
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Depending on the technique, we used antibodies commercially conjugated with horseradish 
peroxidase (Western blot), fluorochromes (Immunofluorescence) and colloidal gold particles (Freeze-
drying). 
Primary and secondary antibodies used in Western blot were prepared in 5% (w/v) non-fat dry 
milk in PBS1x excepting PI3K (p85 subunit) and phospho-tryrosine residues antibodies. These were 
prepared in 5% (w/v) BSA in PBS1x.  
Antibodies used in immunolocalization were prepared in 10% (v/v) FBS in PBS1x and were 
centrifuged at 16000rcf, 4ºC for 5 minutes, before being used. 
 
2.2.2 Cell Lines 
2.2.2.1 3T3-L1 
The main cell line used during this thesis was the Mus musculus (mouse) embryo 3T3-L1 cell 
line acquired from ATCC (ATCC CL-173™). L1 is a continuous substrain of 3T3 (Swiss albino) 
developed through clonal isolation. The cells undergo a pre-adipose to adipose like conversion as they 
progress from a rapidly dividing to a confluent and contact inhibited state. Cells were manipulated as 
stipulated by ATCC. 
 
2.2.2.2 Hek293T 
This is the 293 clone of transformed human embrionary kidney cell lines, generated by 
infection with the adenovirus 5 (Ad 5) DNA. This cell line contains the “early expression region 1” 
(E1) from Ad 5, thus allowing the growth of adenoviruses lacking E1. 293 cells are efficiently infected 
by adenoviruses and are generally used for adenovirus amplification and their quantification. Hek 
293T cells are a subline of Hek 293 cells which stably express SV40 large T antigen allowing 
episomal replication of plasmids containing an origin of replication of SV40. 
 
 
 
 
 
 
18 
 
2.3 Methods 
2.3.1 Cell Culture 
Table 2.4 - Composition of culture mediums used in cell culture protocols 
10% CS medium  
Reagent Final Concentration 
DMEM 4,5g/L Glucose; 2mM L-Glutamine;0,11 g/L Pyruvate 
Penicillin-Streptomycin 100U/mL-100µg/mL 
HEPES 25mM, pH=7.4 
CS 10% (v/v) 
Puromycin dihydrochloride 3µL/mL 
10% FBS medium  
Reagent Final Concentration 
DMEM 4,5g/L Glucose; 2mM L-Glutamine;0,11 g/L Pyruvate 
Penicillin-Streptomycin 100U/mL-100µg/mL 
HEPES 25mM, pH=7.4 
FBS 10% (v/v) 
Puromycin dihydrochloride 3µL/mL 
Fasting Medium  
Reagent Final Concentration 
DMEM 4,5g/L Glucose; 2mM L-Glutamine;0,11 g/L Pyruvate 
Penicillin-Streptomycin 100U/mL-100µg/mL 
HEPES 25mM, pH=7.4 
BSA 0,2% (w/v) 
Freezing Medium  
Reagent Final Concentration 
FBS 90% (v/v) 
DMSO 10%(v/v) 
Differentiation Medium 1  
Reagent Final Concentration 
DMEM 4,5g/L Glucose; 2mM L-Glutamine;0,11 g/L Pyruvate 
Penicillin-Streptomycin 100U/mL-100µg/mL 
HEPES 25mM, pH=7.4 
FBS 10% (v/v) 
Insulin 5µg/mL 
Dexamethasone 0,25µM 
IBMX 0,5mM 
Rosiglitazone 1µM 
Puromycin dihydrochloride 3µL/mL 
Differentiation Medium 2  
Reagent Final Concentration 
DMEM 4,5g/L Glucose; 2mM L-Glutamine;0,11 g/L Pyruvate 
Penicillin-Streptomycin 100U/mL-100µg/mL 
HEPES 25mM, pH=7.4 
FBS 10% (v/v) 
Insulin 5µg/mL 
Puromycin dihydrochloride 3µL/mL 
Hek293T Medium  
DMEM 4,5g/L Glucose; 2mM L-Glutamine;0,11 g/L Pyruvate 
Penicillin-Streptomycin 100U/mL-100µg/mL 
FBS 10% (v/v) 
HEPES 25mM, pH=7.4 
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2.3.1.1 Defrosting Cells (3T3-L1 Cell Lines) 
Cryotubes containing fibroblasts were taken from the liquid nitrogen storage tank and 
submerged in a bath warmed at 37ºC. As soon as the solution started to defrost cells were transferred 
to a 25cm2 culture flask with 10%CS medium (table 2.4). Cells were incubated at 37ºC, 95% humidity 
and 10% CO2. After 12 hours the medium was renewed. 
 
2.3.1.2 Growing/Differentiating cells (3T3-L1 Cell Lines) 
Fibroblasts were maintained in 75 cm2 culture flasks in 10%CS medium (table 2.4) and 
incubated at 37ºC, 95% humidity and 10% CO2. Before reaching confluence, cells were washed twice 
with sterile PBS1x (137mM NaCl; 2,7mM KCl; 4,3mM Na2HPO4; pH=7,4) and trypsinized until cells 
were fully detached. Cells were then counted in a Neubauer chamber and 240.000 cells were seeded 
per 10cm ø plate. Two days after reaching confluence, about 9 days after seeding, cells were induced 
to differentiate by changing to differentiation medium 1 (table 2.4). After 48 hours medium was 
changed to differentiation medium 2 (table 2.4). Two days later, medium was changed to 10% FBS 
medium (table 2.4). Adipocytes were maintained in 10% FBS medium and every two days the 
medium was renovated. 
 
2.3.1.3 Freezing cells (3T3-L1 Cell Lines) 
Fibroblast still in the exponential growth phase were washed twice with sterile PBS1x and 
trypsinized. Cells were recovered to falcon tubes and spun down at 2000 rpm for 3 minutes. The 
supernatant was discarded and cells were resuspended in ice cold freezing medium (table 2.4). Cells 
were transferred to cryovials and stored at -80ºC inside a cryocooler. After 24 hours vials were moved 
to liquid nitrogen storage tank. 
 
Cell culture protocols used for Hek293T cell line were similar to those described above. 
However, cells were maintained in Hek293T medium and were not induced to differentiate. 
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2.3.2 Lentiviral Production and Adipocyte Infection 
For the lentiviral production, we used siRNA obtained from the Functional Genomics Core 
Facility-Institute for Research in Biomedicine Barcelona library. The library contained five different 
siRNAs for cavin 1 and four for cavin 2, in both cases the siRNAs were cloned in pLKO.1 plasmid. 
 
Table 2.5 – Nucleotide sequences of siRNAs used for cavin1 and cavin 2 knockdowns. 
siRNA Oligo Sequence 
Cavin1.1 5’-CCGGGCAGAGTGTTTGGTGGATAAACTCGAGTTTATCCACCAAACACTCTGCTTTTTG-3’ 
Cavin1.2 5’-CCGGGATAAAGAAACTGGAGGTCAACTCGAGTTGACCTCCAGTTTCTTTATCTTTTTG-3’ 
Cavin1.3 5’-CCGGGCCTTTCACCTTCCACGTCAACTCGAGTTGACGTGGAAGGTGAAAGGCTTTTTG-3’ 
Cavin1.4 5’-CCGGGCGCTCCAAGACCGCTGTCTACTCGAGTAGACAGCGGTCTTGGAGCGCTTTTTG-3’ 
Cavin1.5 5’-CCGGAGCGTCAGCAAGTCGCTGAAACTCGAGTTTCAGCGACTTGCTGACGCTTTTTTG-3’ 
Cavin2.1 5’-CCGGCCTGGATAAATTGGTCAACATCTCGAGATGTTGACCAATTTATCCAGGTTTTTG-3’ 
Cavin2.2 5’-CCGGCCTCTCCTTTGGTCGTAAGAACTCGAGTTCTTACGACCAAAGGAGAGGTTTTTG-3’ 
Cavin2.3 5’-CCGGCCAGCCTCAAGAAAGTCGATACTCGAGTATCGACTTTCTTGAGGCTGGTTTTTG-3’ 
Cavin2.4 5’-CCGGGAGAACCAGCACAACATGGAACTCGAGTTCCATGTTGTGCTGGTTCTCTTTTTG-3’ 
 
 
2.3.2.1 Tranfection of Hek293T cells 
Viral production was performed in Hek293T cells. Cells were transfected using the PEI method. 
Plasmid pCMVDR7.8 was used as packaging plasmid and pMD2G as envelope plasmid. 
Hek293T cells were seeded in 10cm ø plates so that they were confluent in the next day. Plates 
contained 10mL of Hek293T medium (Without HEPES) (table 2.4) and incubation conditions were 
the same as those used for adipocytes (37ºC, 95% humidity and 10% CO2). Then 10µg of siRNA, 7µg 
of pCMVDR7.8 and 3µg of pMD2G were mixed and taken to a final volume of 1560µL with sterile 
150mM NaCl. 78µL of PEI (from 1mg/mL, pH=7.0) were then added and the mix was vortexed for 20 
seconds. After 15 minutes, the mix was added to the plate and 7-8 hours later the medium was 
removed and cells were incubated with 5mL of Hek293T medium. Incubation temperature was 
changed to 33ºC.  
 
2.3.2.2 Virus recovery and purification 
Approximately 24 hours after transfection culture medium was recovered, centrifuged at 2500 rpm 
for 10 minutes at 4ºC, then filtered through 0,45µm filter and stored at 4ºC. Cells were incubated with 
another 5 mL of Hek293T medium and again, 24 hours later the medium was recovered, centrifuged 
and filtered as described above. 
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Viruses were then purified through ultracentrifugation on a sucrose cushions. To do so the 
recovered medium was placed in ultracentrifuge tubes and using a syringe, 4ml of 20% sterile sucrose 
was carefully added to the bottom of the tube. Medium were centrifuged at 26000rpm for 1h30 
minutes at 4ºC. The medium and sucrose were discarded, tubes were dried and the pellet containing 
viruses was resuspended in 100µl of DMEM with 100U/mL-100µg/mL penicillin-streptomycin. 
 
2.3.2.3 Infection of 3T3-L1 fibroblasts 
Adipocyte infection was performed in 6-well plates and 20.000 3T3-L1 fibroblasts (low passage) 
were seeded per well. Fibroblasts were cultured in 10% CS medium (table 2.4) without puromycin and 
incubated at 37ºC, 95% humidity and 10% CO2. Four to five hours after seeding, the viruses produced 
and purified as described in the last section were added to the medium and the incubation temperature 
was changed to 33ºC. Approximately 12 hours later the medium was renovated and the temperature 
was returned to 37ºC. Two days later the medium was changed to complete 10% CS medium (table 
2.4) to select infected cells. 
 
2.3.3 Obtention of whole cell lysates 
Plates of 10cm ø with cultured cells were washed twice with PBS1x (137mM NaCl; 2,7mM 
KCl; 4,3mM Na2HPO4; pH=7,4) and incubated for 30 minutes on ice with  1mL of RIPA buffer 
(50mM Tris-base, pH=7,4; 150mM NaCl; 1% (v/v) Igepal CA630; 0,5% (w/v) Sodium deoxycholate; 
0,1% (v/v) SDS) containing a protease inhibitor cocktail (1µg/mL Pepstatin; 1µg/mL Leupeptin; 
0,5mM PMSF; 10µg/mL Aprotinin). Cells were then scrapped off the plates, transferred to eppendorfs 
and homogenized using a syringe with a 25G needle. After homogenization, lysates were placed on a 
shaker for 30 minutes at 4ºC and spun down for 10 minutes at 16000rcf at 4ºC. Supernatant was 
recovered and protein concentration was determined as described in the section below. Lysates were 
stored at -80ºC. 
 
2.3.4 Protein Quantification (BCA method) 
In this thesis protein quantification was performed using the Pierce® BCA Protein Assay 
Reagent which does not interfere with the detergents used in the lysis buffers. 
A standard curve from 0 to 20µg was generated loading the appropriate volumes of 1mg/mL 
BSA (included in the kit) into an ELISA plate and 5µL of protein lysate were used in the 
quantification (all volumes done in duplicates). A reactive solution was prepared according to the 
manufacturer’s instructions (mix solution A with B in a 50:1 ration) and 200µL were loaded in each 
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well. Plates were incubated at 37ºC for 15 minutes and absorbance was read at 562nm in an ELISA 
plate reader, Biowhittaker Microplate Reader 2001. 
 
2.3.5 Protein detection by SDS-PAGE electrophoresis and Western blot 
Table 2.6 – Stacking gel (3.3%) and Running gel (7.5%, 10%) chemical composition. 
Stacking gel (5mL/gel) Running gel (10mL/gel) 
 3,3% Final Con.  7,5% 10% Final Con. 
Acrylamide 30% 0,65mL 3,3% Acrylamide 30% 2,5mL 3,2mL 7,5%/10% 
Tris-HCl 0,5M, pH=6,8 1,25mL 0,125M Tris-HCl 1,5M, pH=8,8 2,5mL 2,5mL 0,375M 
SDS 10% 50µL 0,1% SDS 10% 100µL 100µL 0,1% 
APS 10% 50µL 0,1% APS 10% 100µL 100µL 0,1% 
TEMED 7µL 6,6mM TEMED 10µL 10µL 2,2mM 
H2O Milli-Q Up to 5mL H2O Milli-Q Up to 10mL 
 
Samples were prepared with the desired amount of protein lysates and LSB4x (250mM Tris-
HCL, pH=6,8; 40% (v/v) glycerol; 8% (w/v) SDS; 0,02% (w/v) bromophenol blue) was added, 
diluting it four times, then samples were boiled at 95ºC for 5 minutes. 
Depending on the molecular weight of the protein of interest, the stacking and running gels 
were prepared according to table 2.6 and samples were loaded into the stacking gel. The 
electrophoresis was performed at RT and ran at 100V throughout the time for a good protein 
separation (which depends on the protein of interest and gel percentage), using electrophoresis buffer 
1x (25mM Tris-base; 190mM glycine; 0,1% (v/v) SDS). In the development of this thesis we used 
Mini-Protean® III Electrophoresis System. 
After the protein separation, proteins were transferred to a 0,2µm PVDF membrane. For this 
end we used the Mini-Protean® TransBlot Cell System. The protein transfer procedure occurred on ice 
at 250mA for 120 minutes using transference buffer 1x (25mM Tris-base, pH=8,3; 192mM glycine; 
20% (v/v) Methanol). 
Once the transference was completed, membranes were incubated with the blocking solution (10% 
(w/v) non-fat milk in 0,5% (v/v) Tween-20-PBS1x), for 1hour at RT in a rocking platform (if PI3K-
p85 subunit or phospho-tryrosine residues antibodies were to be used, the blocking solution was 5% 
(w/v) BSA in PBS1x). Membranes were then incubated with primary antibody (table 2.2), o/n at 4ºC. 
After incubation with primary antibody the membranes were washed with washing solution 
(0,01%(v/v) Triton-X-100-PBS1x) at RT in a rocking platform, for 30 minutes, changing the solution 
every 10 minutes. Membranes were then incubated with secondary antibody (table 2.3), for 2 hours at 
4ºC, and washed again as described above. 
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For the chemioluminescent antibody detection, membranes were incubated for 1 minute with a 
mixture (1:1) of ECL solution 1 (0,1M Tris-HCL, pH=8,5; 2,5mM luminol; 0,39mM p-Coumaric acid) 
and ECL solution 2 (0,1M Tris-HCL, pH=8,5; 5,6mM hydrogen peroxide) and then the membrane was 
exposed to a x-ray film. The exposition times varied depending on the intensity of the signal. Films 
were revealed in a FPM100A, Fujifilm® equipment. 
 
2.3.6 Immunoprecipitaton 
 Immunoprecipitation was performed in differentiated adipocytes grown in 10 cm ø plates. 
First cells were serum-fasted, washing twice with PBS1x (137mM NaCl; 2,7mM KCl; 4,3mM 
Na2HPO4; pH=7,4) and incubating them with fasting medium (table 2.4) for 3 hours at 37ºC, 95% 
humidity and 10% CO2.  
After fasting, cells were incubated with 0nM or 100nM insulin for 30 minutes at 37ºC and 
then lysed as described in section 2.3.3 but using lysis buffer (50mM HEPES; 10mM EDTA; 150mM 
NaCl; 1% (v/v) Igepal CA630; pH=7,4) with protease (1µg/mL Pepstatin; 1µg/mL Leupeptin; 0,5mM 
PMSF; 10µg/mL Aprotinin) and phosphatase (10mM Na4P2O7; 100mM NaF; 1mM Na3VO4) cocktail 
inhibitors instead of RIPA buffer. 
Protein concentration of the lysates was determined, as described in section 2.3.4, and samples 
with 500 µg of protein were prepared. 30µl of protein G-sepharose beads and 3µl of specific antibody 
were added to each sample and they were incubated o/n at 4ºC in an orbital agitator. 
In the next day samples were centrifuged at 3000rpm for 3 minutes at 4ºC and the supernatant 
was recovered and stored at -80ºC. Pellet was washed three times with buffer A (50mM HEPES; 
10mM EDTA; 150mM NaCl; pH=7,4) with phosphatase cocktail inhibitor (10mM Na4P2O7; 100mM 
NaF; 1mM Na3VO4). Washings were performed adding buffer A and centrifuging samples at 
3000rpm for 3 minutes at 4ºC and discarding the supernatant. After the washings LSB4x (250mM 
Tris-HCL, pH=6,8; 40% (v/v) glycerol; 8% (w/v) SDS; 0,02% (w/v) bromophenol blue) containing 
0,1M DTT was added to each sample and samples were boiled at 95ºC for 5 minutes. Results were 
analyzed by western blot. 
 
2.3.7 Glucose Transport 
Differentiated adipocytes grown in 6-well plates were serum-fasted, washing twice with 
PBS1x (137mM NaCl; 2,7mM KCl; 4,3mM Na2HPO4; pH=7,4) and incubating with 10mL of fasting 
medium (table 2.4) for 3 hours at 37ºC, 95% humidity and 10% CO2. 
After fasting, cells were washed three times with PBS1x and 0,9mL of Krebs-Ringer-HEPES 
buffer (137mM NaCl; 4,7mM KCl; 1,18mM MgSO4.7H2O; 1,18mM KH2PO4; 2,5mM CaCl2.H2O; 
20mM HEPES, pH=7.4; 0,2% (w/v) BSA; 2mM Sodium pyruvate; pH=7,4) were added to each well. 
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Cells were then incubated, at 37ºC for 30 minutes, with different concentrations of insulin (0nM, 1nM, 
10nM, 100nM). 
After insulin action, 100µL of substract solution (Krebs-Ringer-HEPES buffer; 100µM 2-
deoxyglucose; 1µCi/ml 2-deoxy[H3]-glucose) were added to each well and 5 minutes later the 
transport was stopped adding STOP Buffer at 4ºC (50mM D-(+)-glucose in PBS1x). To eliminate the 
non-incorporated radioactivity, cells were washed three times with STOP buffer at 4ºC. Once the wells 
were dried, 800µL of lysis buffer (100mM NaOH; 0,1% (v/v) SDS) was added and cells were 
scrapped off and homogenized with the pipette. 
To evaluate the amount of incorporated radioactivity, 250µL of lysate were mixed with 3mL 
of scintillation liquid and radioactivity was measured in a β-counter, Tri-CARB 2100TR, Packard®. 
Protein content in the lysate was determined using the Pierce® BCA Protein Assay Reagent as 
described above in section 2.3.4 but loading 10µL of lysate instead of 5µL. 
 
2.3.8 Immunolocalization 
Immunolocalization was performed in permeabilized whole-cell or in plasma membranes of 
differentiated adipocytes grown in glass coverslips (12 mm diameter). In some cases a previous 
stimulation with insulin was performed.  
 
2.3.8.1 Insulin stimulation 
For the insulin stimulation, first cells were serum-fasted, as described in section 2.3.6. Then 
cells were incubated with or without 100 nM insulin for 30 minutes at 37ºC. After insulin action, cells 
were washed three times with PBS1x (137mM NaCl; 2,7mM KCl; 4,3mM Na2HPO4; pH=7,4). 
 
2.3.8.2 Plasma membrane Lawns 
If immunolocalization was to be done in plasma membrane lawns, the following protocol was 
performed. 
Cells grown in glass coverslips were washed twice with PBS1x and then incubated with poly-
L-lysine (0,5mg/mL) in PBS1x for 1 minute at RT. The solution was removed and cells were washed 
again with PBS1x. Cells were then swollen by incubation with KHMgE 1/3x buffer (1x concentration, 
70mM KCl; 30mM HEPES, 5mM MgCl2; 3mM EGTA; pH=7,5) for 5 minutes at RT. The medium 
was removed and cells were placed in KHMgE 1x buffer and then ruptured using a plastic Pasteur 
pipette. Membranes were washed with PBS1x. 
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2.3.8.3 Immunolocalization 
Plasma membrane lawns or whole adipocytes, grown in glass coverslips, were fixed in 3% (v/v) 
PFA in PBS1x for 15 minutes at RT. PFA was removed and cells/membranes were washed three times 
with PBS1x and then incubated, for 10 minutes at RT, with 50mM NH4Cl in PBS1x. NH4Cl solution 
was removed and cells/membranes were placed in 20mM glycine in PBS1x for another 10 minutes at 
RT. If the protocol was being done in whole-cells, a permeabilization step was necessary and so, 
glycine was removed and cells were incubated with 0,1% (v/v) Triton X-100 in PBS1x, for 10 minutes 
at RT. Then cells/membranes were washed three times with PBS1x and nonspecific binding sites were 
blocked with 10% (v/v) FBS in PBS1x, for 30 minutes at RT. 
Incubation with primary antibodies (table 2.2) was done for 1 hour at RT, placing a 25µL drop of 
antibody solution in each coverslip. After the incubation cells/membranes were washed three times 
with PBS1x and then incubated with the secondary antibody (table 2.3), as described for the primary. 
During the incubation, cells/membranes were protected from light since the fluorochrome attached to 
the secondary antibody is photosensitive. Cells/membranes were washed again three times with 
PBS1x and dried at RT. 
Coverslips were mounted with ProLong® Gold antifade reagent and viewed in a Leica TCS SPE 
spectral confocal microscope. 
 
2.3.9 Freeze-Drying 
2.3.9.1 Obtention of plasma membrane lawns and immunogold 
Differentiated adipocytes, grown in glass coverslips, were disrupted as described in section 2.3.8.2 
in order to obtain plasma membrane lawns and all the procedure was performed on ice cold plates. 
Then membranes were fixed with 3% (v/v) PFA in PBS1x (137mM NaCl; 2,7mM KCl; 4,3mM 
Na2HPO4; pH=7,4) for 15 minutes. PFA was removed and membranes were washed three times with 
PBS1x. Antibody nonspecific binding sites were blocked with 10% (v/v) FBS in PBS1x, for 30 
minutes. After blocking, the incubation with primary antibody (table 2.2) was done for 1 hour, placing 
a 25µL drop of antibody solution in each coverslip. After the incubation, membranes were washed 
three times with PBS1x and then incubated with the secondary antibody (table 2.3), as described for 
the primary. Membranes were washed again three times with PBS1x. 
 
2.3.9.2 Freeze-Drying 
Membranes were fixed with 2,5% glutaraldehyde in PBS1x for 15 minutes and then washed with 
H2O Milli-Q and cryoprotected with 10% methanol. The sample was ultrarapidly frozen impacting it 
onto a block of cooled copper (slam-freezing) and then transferred to a freeze-drying device (BAF-
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060, Bal-Tec, Liechnstein) and the surface ice was removed at -90ºC, 10-7mbar for 90 minutes. A thin 
layer of platinium (23º, 1nm) was evaporated rotationally onto the sample to produce replicas of the 
surface of the membrane and next replicas were reinforced with a carbon layer (75º, 10nm). Replicas 
were separated from the coverslip with 30% hydrofluoric acid and the organic material was digested 
with bleach for 12 hours. Finally replicas were washed with H2O Milli-Q, mounted on copper grids 
and covered with Formvar resin. Observations were done in a JEOL 1010 Transmission Electron 
Microscope. 
2.3.10 Oil red staining 
Oil Red staining is a technique used to stain neutral lipid inside the cell. For this protocol a 
8,5mM OilRed O stock solution was prepared diluting Oil Red O in isopropanol and letting it stirring 
overnight, at RT. The stock solution was then filtered with 0,2µm filter. 
Differentiated adipocytes were fixed with 3% PFA for 15 minutes at RT.  The PFA was 
removed and cells were washed with 60% isopropanol. The cells were then incubated with working 
solution (60% OilRed O stock; 40% H2O Milli-Q), previously filtered with 0,2µm filter, for 10 
minutes at RT. Working solution was removed and cells were washed three times with H2O Milli-Q. 
Adipocytes were observed in a phase contrast microscope. 
 
2.3.11 Triglyceride Quantification 
Triglyceride quantification in total lysates was performed using the Biosystems Triglyceride 
assy kit. Differentiated adipocytes were lysed as described in section 2.3.3 but using an 
homogenization buffer (0,25M Sucrose; 2mM EGTA; 20mM HEPES; pH=7,4) with protease 
inhibitors (1µg/mL Pepstatin; 1µg/mL Leupeptin; 0,5mM PMSF; 10µg/mL Aprotinin) instead of 
RIPA buffer. 
A standard curve from 0 to 200mg/dL was generated loading serial dilutions of the 200mg/dL 
triglycerides standard solution (included in the kit) into the ELISA plate and 10µL of the lysate were 
used in the quantification (done in duplicates). Then 200µL of reactive solution (included in the kit) 
were added to each well and plates were incubated 5 minutes at 37ºC. After incubation plates were 
read at 500nm. 
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3. Results 
3.1 Obtention of 3T3-L1 cell lines deficient in Cavin 1 and Cavin 2 
 
In the development of this thesis we wanted to study the role of cavin 1 and cavin 2 in the 
functioning of adipocytes. The first step to achieve our goal consisted in developing one 3T3-L1 
multiclonal cell line deficient in cavin 1 and another one in cavin 2.  
To reduce the expression of these proteins we used a post-transcriptional gene silencing 
approach. The KD consisted in infecting 3T3-L1 pre-adipocytes (fibroblasts) with lentiviruses able to 
integrate in the genome of these cells and express hairpin siRNA sequences. As decribed in section 
2.3.2 we had five siRNA sequences for cavin 1 and four sequences for cavin 2.  
We were not able to grow cells infected with lentivirus containing the sequences cavin1.3 and 
cavin1.4, so we managed to obtain four cell lines for cavin 2 KD, three for cavin 1 KD and a control 
cell line in which we used a scrambled siRNA sequence. Reduction in cavin expression levels was 
assessed by western blot assay using lysates of both fibroblasts and differentiated adipocytes (figure 
3.1). As represented in figure 3.1, in adipocytes we could obtain a reduction of cavin 1 in all cavin1.1, 
cavin1.2 and cavin1.5 cell lines. For cavin 2, we obtained a greater reduction on clones cavin2.3 and 
cavin2.4. In fibroblasts we only detected cavins in control cells although at low levels. 
Taking into account the level of protein reduction, the KD stability through the cell passages 
and the differentiation capability, we selected one KD clone for each cavin. The two selected clones 
were cavin1.5 and cavin2.3 for cavin 1 and cavin 2 KDs, respectively. In figure 3.2 it is represented 
the cavin 1 and cavin 2 reduction obtained in both selected clones. For cavin1.5 clone we were able to 
obtain a reduction of 65% in the expression of cavin 1. Regarding cavin2.3 clone we obtained a KD of 
97% in cavin 2 expression. We also observed that cavin1.5 cells, besides the reduction in cavin 1 
Figure 3.1 – Cavin 1 and cavin 2 expression in 3T3-L1 fibroblasts and adipocytes infected with lentiviruses 
containing scrambled or different cavin siRNA sequences of both proteins. 50µg of protein from cell lysates 
were used to analyze cavin 1 and cavin 2 expression by SDS-PAGE followed by western blot assay with an anti-
cavin1 and cavin 2 specific antibodies. 
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expression, also had lower levels of cavin 2 (48% less than control cells). The same observation was 
made for cavin2.3, besides the lower levels of cavin 2, these cells had a reduction of 54% in the 
expression of cavin 1. 
In order to confirm the reduction in cavin 2 levels and to observe its membrane distribution, in 
both cavin1.5 and cavin2.3 cells, we performed an immunolocalization of cavin 2 in plasma 
membrane lawns of these cells.  
Analysing both figure 3.3 and figure 3.4 we observe that cavin 2 levels are reduced in both 
KD cells when compared with control cells which is accordant with the western blot results and 
because cavin 2 is localized in caveolae we can also observe that caveolae are absent/altered in KD 
cells (figure 3.4 and 3.5). These results indicate that cavin 2 is important for caveolae correct 
formation. The absent/altered caveolae are even more evident in figure 3.5. Cavin2.3 KD cells have 
Figure 3.2 – siRNA mediated downregulation of cavin 1 (A) and cavin 2 (B) expression in 3T3-L1 adipocytes. 
50µg of protein from cell lysates were used to analyze cavin 1 and cavin 2 expression by SDS-PAGE followed by 
western blot with anti-cavin 1 and cavin 2 antibodies. Cell lysates were recovered 12 days after the induction of 
differentiation. In the western blot band quantification, each data point represents the mean ±SEM derived from six 
independent experiments normalized to control cells. One-way ANOVA test was performed between KD and 
control cells. ***, P≤0,001;**, P≤0,01.  
A B 
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less caveolae and some of them show a torus shape (green arrows) and others appear completely flat 
(white arrows). 
The level of reduction in the cavin 2 levels could not be quantified using the images in figure 
3.3 since they were acquired using different settings, otherwise no signal would be observed in 
cavin2.3 KD cells images. These changes were done so that one could observe the differences in 
caveolae structure.  
The same experiments were performed using anti-cavin 1 antibody but the antibody our 
laboratory possessed failed to work properly in immunoflourescence experiments. 
Figure 3.3 – Distribution of cavin 2 in plasma membranes of control, cavin 1 KD and cavin 2 KD cells. Control 
and KD adipocytes, 12 days after the induction of differentiation, were subjected to immunolocalization in plasma 
membrane lawns (as described in section 2.3.8 of materials and methods) using anti-cavin 2 specific antibody. 
Observations were made in a confocal microscope with 63x objective. Caveolae bunches are indicated by white 
arrows. 
Cavin 2 
Cavin1.5 Control Cavin2.3 
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Figure 3.4 – Cavin 2 distribution in replicas of the cytosolic leaflet of the cell 
membrane of control (A) and cavin2.3 (B) cells. Cells in the 12th day of 
differentiation were processed in order to obtain plasma membrane lawns and 
then cavin 2 was immunolocalized using a specific antibody (as described in 
section 2.3.9.1 of materials and methods). Membranes were then subjected to 
freeze-drying technique (as described in section 2.3.9.2 of materials and 
methods) and observed in an electron microscope. Arrows indicate caveolae 
and white dots are the gold particles associated with the secondary antibody 
and represent cavin 2 distribution. 
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Figure 3.5 – Replicas of the cytosolic leaflet of the cell membrane of control (A) and 
cavin2.3 (B) cells. Cells in the 12th day of differentiation were processed in order to 
obtain plasma membrane lawns (as described in section 2.3.8.2 of materials and 
methods) and then subjected to freeze-drying technique (as described in section 2.3.9.2 
of materials and methods) and observed in an electron microscope. Arrows indicate 
normal (red), torus shaped (green) and flattened (white) caveolae. Bar, 200nm 
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3.2 Differentiation of 3T3-L1 cell lines deficient in Cavin 1 and Cavin 2 
 
After obtaining the 3T3-L1 cell lines deficient in cavin 1 and cavin 2 we wanted to analyze the 
capacity of these cells to differentiate. By optical microscope analysis one can evaluate the cellular 
differentiation analyzing the number and size of differentiated cells and its LDs. In figure 3.6, we 
observe that the number of differentiated cavin1.5 adipocytes is lower than the one observed in control 
and cavin2.3 cells, which is similar. Despite this, cavin1.5 and cavin2.3 adipocytes cells are bigger 
than control cells and have larger LDs. The difference in the size of LDs is clear in figure 3.6B, and 
because LDs store TAG we decided to quantify TAG in total lysates (figure 3.7). 
Figure 3.6 – Microscopic observation of 3T3-L1 control cells and cavin 1 and cavin 2 KD cells, not stained (A) 
and stained (B) with Oil Red O. A) Pre-adipocytes were induced to differentiate and 12 days after induction cells 
were observed in a phase contrast microscope with 10x objective. B) Adipocytes in the 12th day of differentiation 
were fixed and stained with Oil Red O (as described in section 2.3.10 of materials and methods) and observed in a 
phase contrast microscope with 10x objective. LDs are indicated by black arrows. 
Control Cavin1.5 Cavin2.3 
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 In this quantification we observe that the level of TAG in cavin2.3 cells is higher than in 
control cells but this difference is not significative, on the other hand TAG levels are lower in cavin1.5 
cells (around 50%). Since we quantified TAGs in total lysates and not only in differentiated cells, the 
fact that fewer cavin1.5 fibroblast are differentiated may account for the lower levels of TAG observed 
in total lysates of cavin1.5 cells.  
Taken together these results indicate that cavin2.3 cells have similar differentiation profiles to 
those of control cells but that differentiation in cavin1.5 KD cells is affected. 
 
To continue the analysis of the KD cells capability to differentiate we performed western blot 
assays to verify the expression levels of proteins markers of differentiated adipocytes such as caveolin-
1, GLUT4, perilipin, ATGL, Fat acid binding protein 4 (FABP4) and IR (figure 3.8). 
We verified that most of the proteins have similar expression levels. Caveolin-1 and IR levels 
are not altered in KD cells, although cavin1.5 has lower but not significant caveolin-1 expression. The 
lower levels of expression in cavin1.5 cells are also evident for ATGL and FABP4. However none of 
these differences are statistically relevant, as shown for caveolin-1 (figure 3.8 B). These results are 
consistent with the microscopic observation where cavin1.5 cells show a worst differentiation profile. 
On other hand, levels of GLUT4 and perilipin are altered in KD cells. GLUT4 protein levels 
showed a decrease of 89% in cavin1.5 cells and 47% in cavin2.3 when compared with control cells 
(figure 3.8 B). Expression level of perilipin it is decreased in cavin1.5 cells (around 55% less) and 
increased in cavin2.3 cells but this difference is not statistically relevant (figure 3.8 B). 
Considering that cavin1.5 cells have lower percentage of differentiated adipocytes and that we 
analyzed total lysates, it is not surprising that the expression levels of these differentiation markers is 
lower than that of control cells. 
 
 
 
Figure 3.7 – TAG levels in total cell lysates of control, cavin1.5 
and cavin2.3 cells. Control and KD adipocytes on the 12th day of 
differentiation were lysed and subjected to TAG quantification (as 
described in section 2.3.11 of materials and methods). Each data 
point represents the mean ±SEM derived from two independent 
experiments. One-way ANOVA test was performed between KD 
and control cells. *, P≤0,05. 
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As previously referred, cavins are present in plasma membrane domains called caveolae, these 
structures are enriched in caveolin-1 which is its more abundant protein. Since levels of caveolin-1 in 
total lysates are similar in control and KD cells we decided to immunolocalize caveolin-1 in plasma 
membrane lawns of differentiated adipocytes in order to observe if caveolin-1 distribution is normal 
and to analyze caveolae structure. In figure 3.9 and 3.10 one observes that KD cells have less 
caveolin-1 in the plasma membrane than control cells, however, in figure 3.9 this is not so obvious for 
cavin2.3 cells since the images have a lot of background signal which could be confused with caveolin 
signal. As for the structure of caveolae, like observed with anti-cavin 2 antibody (figure 3.3 and 3.4), 
caveolae are altered/absent in both KD cells. Comparing these results with the ones in figure 3.3, 3.4 
and 3.5 it seems that lack of cavins affects with great extent caveolae formation. 
A B 
Figure 3.8 – Expression levels of protein markers of adipocyte differentiation in control and KD cells. A) 3T3-
L1 control cells and KD cells were lysed 12 days after the induction of adipocyte differentiation and 50µg of cell 
lysates (5µg for caveolin-1 and GLUT4) were resolved by SDS-PAGE and analyzed by western blot with 
specific antibodies for protein markers of adipocyte differentiation. B) Quantification of western blot bands 
obtained for caveolin-1, GLUT4 and perilipin. Each data point represents the mean ±SEM derived from 
independent experiments (six for caveolin-1 and perilipin and five for GLUT4) normalized to control cells. One-
way ANOVA test was performed between KD and control cells. ***, P≤0,001; *, P≤0,05. 
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Figure 3.9 – Distribution of caveolin-1 in plasma membranes (cytosolic leaflet) of control and KD cells. Control 
and KD adipocytes, 12 days after the induction of differentiation, were processed in order to obtain plasma 
membrane lawns and caveolin-1 was immunolocalized with a specific antibody (as described in section 2.3.8 of 
materials and methods). Observations were made in a confocal microscope with 63x objective. Caveolae are 
indicated by white arrows. 
Caveolin-1 
Control Cavin1.5 Cavin2.3 
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Figure 3.10 – Caveolin-1 distribution in replicas of the cytosolic leaflet of the 
cell membrane of control (A) and cavin2.3 (B) cells. Cells in the 12th day of 
differentiation were processed in order to obtain plasma membrane lawns and 
then cavolin-1 was immunolocalized using a specific antibody (as described in 
section 2.3.9.1 of materials and methods). Membranes were then subjected to 
freeze-drying technique (as described in section 2.3.9.2 of materials and 
methods) and observed in an electron microscope. Red arrows indicate caveolae 
and white dots represent caveolin-1 distribution. 
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Perilipin is one of the most abundant proteins in the membrane of LDs and in order support 
the previous observation about LDs size and perilipin content we performed an immunolocalization of 
perilipin in control and KD cells (figure 3.11). The immunolocalization allowed us to confirm that KD 
cells have bigger LDs than control cells, however we could not observe any differences in the amount 
of this protein. 
 
3.3 Insulin responsiveness of 3T3-L1 cell lines deficient in Cavin 1 and Cavin 2 
 
GLUT4 is the insulin-regulated glucose transporter found in adipose tissues and since the 
levels of this transporter are reduced in KD cells we decided to evaluate the ability of these cells to 
transport glucose in response to insulin. 
Analyzing the insulin-responsive transport of cavin2.3 cells (figure 3.12 A) one observes that 
these cells only respond to insulin at a concentration of 10nM while control cells respond at 1nM. At 
10nM already exists a significant difference between control and cavin2.3 cells and this difference 
increases at 100nM insulin. Summarizing, KD cells are less insulin-sensitive because they need higher 
insulin concentration (than control cells) to increase glucose transport and the response to the hormone 
is less effective because glucose uptake at 10nM and specially at 100nM of insulin is significantly 
lower in cavin2.3 cells. 
Figure 3.11 – Distribution of perilipin in LDs of control and KD cells. Control and KD adipocytes, 12 days after the 
induction of differentiation, were subjected to immunolocalization in whole-cells (as described in section 2.3.8 of 
materials and methods) using anti-perilipin antibody. Observations were made in a confocal microscope with 63x 
objective. LDs containing perilipin in its surface are indicated by white arrows. 
Control Cavin1.5 Cavin2.3 
Perilipin 
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Regarding cavin1.5 cells responsiveness to insulin (figure 3.12 B) we observed that these KD 
cells do not respond to any of the insulin concentrations used in this experiment, which is not 
surprising considering that cavin1.5 cells have low levels of GLUT4. Apart from the cavin 1 KD cells 
unresponsiveness to insulin, we observed that the only significant difference between control and 
cavin 1 KD cells occurs at basal state. Cavin1.5 cells have a much higher basal transport of glucose 
than control cells. The higher basal uptake may result from the fact that cavin1.5 cells have less 
differentiated adipocytes, therefore the content of fibroblasts in the sample is high. Fibroblasts 
primarily use GLUT1 as a glucose transporter which is not an insulin-regulated glucose transporter 
and so it is not surprising that these cells have higher basal glucose transport.  
In order to verify if the differences observed in glucose uptake in response to insulin are 
caused by deficiencies in the insulin signaling pathway we performed immunoprecipitations and 
western blot assays to verify the levels of phosphorylated proteins involved in this signaling cascade. 
We analyzed expression levels of total Akt and Akt phosphorylated in serine 473, phosphotyrosine-
IRS-1, phosphotyrosine-IR and PI3K (p85 subunit) linked to IRS-1. Quantifying several western blot 
results we obtained the graphics pictured in figure 3.13. Analyzing figure 3.13 we observe that 
although we see some differences between control, cavin1.5 and cavin2.3 cells, none of them are 
statistically significant.  
A B 
Figure 3.12 – Glucose uptake in response to different insulin concentrations by control and KD cells. Control, 
cavin2.3 (A) and cavin1.5 cells (B) were incubated for 30 minutes with different insulin concentrations and glucose 
uptake (during 5 minutes) was measured by 2-[H3]-deoxyglucose uptake as described in materials and methods 
section 2.3.7. Each data point represents the mean ±SEM derived from independent experiments (nine for 
cavin2.3cells and eight for cavin1.5). One-way ANOVA test was performed between KD and control cells. ***, 
P≤0,001; **,P≤0,01; *, P≤0,05. 
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Figure 3.13 – Expression levels of phosphorylated proteins involved in the insulin signaling cascade. A) 3T3-L1 
control cells and KD cells, 12 days after the induction of adipocyte differentiation, were incubated with (insulin) or 
without (basal) 100nM insulin for 30 minutes (as described in section 2.3.8.1 of materials and methods). Cells were 
lysed and 50µg of cell lysate was resolved by SDS-PAGE and analyzed by western blot with antibodies for Akt and 
Akt phosphorylated in serine473 (sections 2.3.3 and 2.3.5 of the methods). B) 3T3-L1 control cells and KD cells, 
12 days after the induction of adipocyte differentiation, were incubated with (insulin) or without (basal) 100nM 
insulin for 30 minutes. Cells were lysed and 500µg of cell lysate was used for immunoprecipitation with an anti-
phosphotyrosine (B1) or anti-IRS1 (B2) antibodies. Then pellets were washed and resolved by SDS-PAGE and 
analyzed by western blot with antibodies for IRS-1, IR (B1) and PI3K (p85 subunit) (B2) (as described in section 
2.3. of materials and methods). In the quantification of western blot bands, each data point represents the mean 
±SEM derived from independent experiments (Five for Akt and Akt-P; four for IR-P; three for p85 and IRS1) 
normalized to control cells in basal state. One-way ANOVA test was performed between KD and control cells 
stimulated with insulin. 
A 
B1 
B2 
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Since no major differences were observed in the insulin signaling pathway we decided to 
analyze the translocation of GLUT4 to the membrane in response to insulin. To do so we performed an 
immunolocalization of GLUT4 in permeabilized whole cells and in plasma membrane lawns of 
differentiated adipocytes (control and KD cells) incubated with or without insulin. 
Analyzing whole-cells experiments  (figure 3.14) we observe that the amount of GLUT4 is 
higher in control cells than in KD cells, as seen by western blot (figure 3.8), and that in basal 
conditions (no insulin stimulation) GLUT4 localizes inside the cell in both control and KD cells. 
However, upon insulin stimulation GLUT4 moves to the membrane in control cells but not in KD 
cells.  
Regarding plasma membrane lawns (figure 3.15) the same phenomenon observed in whole-
cells experiments happens. In basal conditions few GLUT4 is localized at the membrane, which is 
normal because it is mainly inside the cell and upon insulin stimulation GLUT4 level increases in 
control cells but not in KD cells. 
Summarizing, KD cells fail to translocate GLUT4 to the membrane in response to insulin and 
so this defect contributes to the lower glucose uptake after insulin stimulation. 
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Figure 3.14 – Distribution of GLUT4 in permeabilized whole control and KD cells in the presence or absence of 
insulin. Control and KD adipocytes, 12 days after the induction of differentiation, were incubated with or without 
(basal) 100nM insulin for 30 minutes and then subjected to immunolocalization (as described in section 2.3.8 of 
materials and methods) using anti-GLUT4 specific antibody. Observations were made in a confocal microscope with 
63x objective. GLUT4 inside the cell is indicated by white arrows and GLUT4 at the plasma membrane is indicated 
by green arrows. 
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Figure 3.15 – Distribution of GLUT4 in plasma membrane lawns of control and KD cells in the presence or absence 
of insulin. Control and KD adipocytes, 12 days after the induction of differentiation, were incubated with or without 
(basal) 100nM insulin for 30 minutes. Cells were processed in order to obtain plasma membrane lawns and then 
subjected to immunolocalization (as described in section 2.3.8 of materials and methods) using anti-GLUT4 specific 
antibody. Observations were made in a confocal microscope with 63x objective.  
43 
 
4. Discussion 
The objective of this thesis is to determine the role of the caveolar proteins, cavin 1 and 
cavin 2, in adipocyte functioning. To do so, we performed a siRNA-mediated KD of each 
protein in 3T3-L1 cell line. 
 
Our results show that the reduction of 65% in cavin 1 expression that we obtained in the 
cavin 1 KD cells is sufficient to affect the differentiation of these cells. 
As mentioned in the results section, the percentage of cavin 1 KD pre-adipocytes that 
manage to differentiate is much lower than that of control cells. However at the exception of 
perilipin and GLUT4, none of the differentiation markers expression was substantially reduced. 
In fact, the expressions of all of them were decreased but only perilipin and GLUT4 presented 
statistically relevant reductions. None the less, in some cases, like ATGL and FABP4, an 
increase in the number of experiments might be sufficient to make the protein reduction 
statistically relevant, since the error bars obtained in the western quantification were too high 
(data not shown). In cavin 1 KD cells we also observed a reduction of 48% in cavin 2 
expression levels. This observation is accordant with previous results published by Bastiani et 
al. (2009) that showed a reduction in cavin 2 levels in cavin 1 3T3-L1 KD cells. 
Cavin 1 KD adipocytes also presented bigger size and larger LDs (figure 3.6 and 3.11) 
which could explain why cavin 1 KD cells are less responsive to insulin (Le Lay et al., 2001). A 
TAG quantification in total lysates revealed that cavin 1 KD cells do not have higher TAG 
content despite the bigger LDs. However, as previously explained, in total lysates, the ratio of 
pre-adipocytes/adipocytes is higher in cavin 1 KD cells and so the TAG/protein ratio is 
decreased. This decrease in TAG content that we observed is also not consistent with previous 
studies obtained by our group (González-Muñoz et al., 2009) in which a KD of caveolin-1 (a 
protein functionally related to cavin 1) in 3T3-L1 did not affect the TAG cellular content. 
Thereby, we consider that the lower levels of TAG that we have quantified in cavin 1 KD cells 
are just a consequence of the high content of fibroblasts in the lysates. On the other hand, cavin 
1 has been found in LDs, associated with caveolin-1, and has been implicated in controlling 
lipolysis together with HSL (Aboulaich et al., 2006). This suggests that the absence of cavin 1 
could reduce the cell lipolytic activity, which would lead to an increase in LDs size. 
Bigger LDs could also mean that cavin 1 KD cells have more perilipin, since this a 
component of its surface membrane, but instead, we obtained lower perilipin levels in total 
lysates. Immunolocalizing perilipin (figure 3.11) in whole-cells showed that there are no major 
differences in the LD perilipin content in differentiated control and cavin 1 KD adipocytes. 
Again this could be caused by the fact that less cavin 1 KD cells are induced to differentiate. 
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The fact that the KD of cavin 1 affected the differentiation of 3T3-L1 cells is in line 
with previous published results. Liu et al. (2008) observed that cavin 1-KO mice presented high 
circulating TAG levels, significantly reduced adipose tissue mass, glucose intolerance, insulin 
resistance and hyperinsulinemia which are all conditions of a lipodystrophic phenotype. Indeed, 
recently published data identified cavin 1 as a locus for human lipodystrophy (Garg, 2011; 
Hayashi et al., 2009). 
 
Accordant with other studies (Hansen et al., 2009; Hill et al., 2008; Liu and Pilch, 
2008) we observed that knocking down cavin 1 results in a reduction and morphological 
alteration of caveolae showing that cavin 1 is essential to this structures (figure 3.3 and 3.9). 
Our group (González-Muñoz et al., 2009) also observed that the absence of caveolae results in a 
reduction at the protein level of GLUT4 (50%). This reduction was also observed in this work 
(figure 3.8), although in a much higher extent (89%). Part of the reduction might be due to the 
referred differentiation problem of the cavin 1 KD cells but it is also a consequence of the lack 
of cavin 1 as shown in figure 3.14. 
Apart from GLUT4, our group (González-Muñoz et al., 2009) also observed a reduction 
of the IR in caveolin-1 KD adipocytes as did Liu et al.(2008) in cavin 1-KO mice. In our work 
we were not able to see this decrease. However, in both cases the models with which they work 
were different from ours. In Liu et al. (2008) the experiments were performed in a KO mice in 
which cavin 1 is completely absent, maybe in these conditions is possible to see the decrease in 
IR levels but not in ours (with 65% cavin 1 reduction). Moreover in in vitro experiments the 
culture conditions and medium are very different from those existing in in vivo models. In the 
case of González-Muñoz et al. (2009) the experiments were performed in 3T3-L1 cells deficient 
in caveolin-1 (95% reduction), not cavin 1, thereby we speculate that caveolin-1 could be more 
important in stabilizing IR than cavin 1. It is also a fact that in both studies the absence of 
caveolae was much greater than the one we observed. 
Many studies have linked cavin 1 and caveolin expressions. It has been shown that in in 
vivo models the KO of cavin 1 results in a great reduction of caveolin-1 (Liu et al., 2008). In in 
vitro studies the same has been shown knocking down cavin 1 in 3T3-L1 cells (Hill et al., 2008; 
Liu and Pilch, 2008). As shown in figure 3.8, we failed to do this observation. Regarding the in 
vivo experiments, the difference might be due to the same reasons we stated above for the IR 
expression levels. As for the Liu and Pilch (2008) model, the cavin 1 reduction they have 
obtained was greater than ours and this difference may be sufficient to reach a threshold where 
the lack of cavin 1 affects caveolin-1 levels. The importance of the cavin 1 KD percentage is 
evident in the work of Hill et al. (2008), they observed that a reduction of cavin 1 by 80-95% 
caused a 10-50% reduction of caveolin-1 protein levels. Moreover our results are in line with 
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the ones obtained by Bastiani et al., 2009 in which cavin 1 KD in 3T3-L1 cells have little effect 
over caveolin-1 levels in total lysates.  
 
Besides the cavin 1 KD, we also obtained a cavin 2 KD cell line. In contrast with the 
first, the differentiation of cavin 2 KD cells was not affected by the absence of this protein (97% 
reduction). Cavin 2 KD adipocytes presented a similar morphology to that of cavin 1 KD 
adipocytes, which means bigger cells and LDs when comparing with control cells. These 
differences are even more evident in cavin 2 KD cells than in cavin 1 KD cells (figure 3.6 and 
3.11). Again, this is characteristic of cells with reduced insulin sensitivity (Le Lay et al., 2001). 
In the case of cavin 2 KD cells, TAGs quantification and perilipin protein levels in total lysates 
(figure 3.7 and 3.8) were slightly higher than those of control cells, but these differences were 
not statistically significant. However, these observations are accordant with the fact that cavin 2 
KD cells have bigger LDs. Besides the reduction in GLUT4 levels, which will be discussed 
later, the expression of all the differentiations markers analyzed was not altered, thereby our 
results suggest that cavin 2 is not essential for adipocyte differentiation. 
As observed for the cavin 1 KD cells, the reduction of the expression of cavin 2 also 
resulted in a reduction of cavin 1. This means that cavin 1 and 2 have interdependent 
expressions as previously shown (Bastiani et al., 2009). Pilch group, in non-published data has 
even observed that in cavin 2 KD cells cavin 1 is redistributed to the cytosol. We have not 
confirmed this observation because we could not perform cavin 1 immunolocalization 
experiments. Analyzing the percentages of reduction in cavin 1 and cavin 2 expressions we can 
assume that cavin 1 KD has a greater effect in cavin 2 expression than the reverse. 
In previous studies (Bastiani et al., 2009; Hansen et al., 2009) cavin 2 was localized in 
caveolae and considered essential for its morphology. Our results also show that cavin 2 
localizes in caveolae and that caveolae number is decreased in cavin 2 KD cells (figure 3.3, 3.4, 
3.5 and 3.9), supporting the previous studies. Other works have revealed that the KD of cavin 2 
in HeLa cells leads to a decrease in the levels of the most studied caveolar protein, caveolin-1. 
On the other hand Bastiani et al.(2009) have also performed a KD of cavin 2 in 3T3-L1 and 
they did not found a significant reduction in the caveolin-1 levels. Our results are in agreement 
with Bastiani’s since we did not see any differences in caveolin-1 levels in total lysates but we 
did see a reduction in the plasma membrane. So the question is, where is caveolin-1? It has been 
described that caveolin-1 is present in LDs although its role in this location is still unclear 
(Blouin et al., 2008; Robenek et al., 2010). Moreover, it was previously observed that the size 
in LD increases with the content of caveolin in the same (in obese rodent models and human 
adipocytes) (Blouin et al., 2010), thereby it is possible that caveolin-1 is localizing in the 
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surface of LDs in both cavin KD adipocytes, where it would be stable. One should 
immunolocalize caveolin-1 in whole-cells to determine the localization of this protein. 
 As happened with cavin 1 KD, the downregulation of cavin 2 leads to the loss of 
caveolae and consequently to a decrease in GLUT4 levels, which is in agreement with 
González-Muñoz et al. (2009) experiments. We obtained a 47% decrease in GLUT4 levels as 
did González-Muñoz with a caveolin-1 deficient 3T3-L1 cell line. However, despite the absence 
of caveolae, we could not see differences in the levels of IR, neither with cavin 2 nor cavin 1 
KD. Since we did not observe any differences in total caveolin-1 levels, we speculate that not 
only caveolae but also caveolin are directly related with IR stabilization in the membrane and 
so, the caveolin which is still present in the membrane of our cells might be enough to stabilize 
the IR. 
Our results also showed that the ability of cavin 1 and cavin 2 KD cells to respond to 
insulin increasing glucose transport is impaired (figure 3.12). 
In cavin 1 KD cells we observed that there is no significant increase in the glucose 
uptake in response to insulin, which is not surprising considering the reduction in GLUT4 
levels, the main insulin-responsive glucose transporter (figure 3.8). This inability to respond to 
insulin is in line with the results obtained by Pilch group in which cavin 1 KO lipodystrophic 
mice presented insulin resistance and hyperinsulinemia (Liu et al., 2008). Our results also 
showed a high basal glucose uptake in cavin 1 KD cells but, has previously referred, this is due 
to the high fibroblast content in the samples. Pre-adipocytes have a high basal glucose uptake 
due to high expression of GLUT1 (Yeh et al., 1995). 
In contrast to cavin 1, cavin 2 KD cells responded to insulin, however this insulin action 
was 60% lower than that of control cells. Similar results were obtained in previous works of our 
group. González-Muñoz et al. (2009) obtained a 50% reduction in glucose uptake by cells 
lacking caveolin-1 which also had 50% less GLUT4 while we obtained a reduction of 60% in 
glucose uptake by cells with 50% less GLUT4. Our results also showed that cavin 2 KD cells 
were less insulin-sensitive since we needed a higher insulin concentration to increase glucose 
uptake. 
In both KD cells, the impaired increase in glucose transport induced by insulin is not 
surprising considering the GLUT4 levels, however our results revealed that this is not the only 
reason. Immunolocalizing GLUT4 in whole cells and plasma membrane lawns, after insulin 
stimulation, revealed that this transporter was not being translocated to the plasma membrane 
(figure 3.14 and 3.15). This could be caused by an alteration in the insulin-signaling pathway, 
however we did not detect any significant difference in the signaling cascade (figure 3.13), 
although Liu et al. (2008) reported a reduction in phosphorylated Akt levels (phosphorylation in 
ser473) in cavin 1 KO mice. As previously discussed, this can be a consequence of the 
47 
 
differences that exist between in vivo and in vitro experiments. On the other hand, González-
Muñoz et al. (2009) did not found any changes in the insulin cascade in caveolin-1 deficient 
adipocytes. Some key points in this pathway, like AS160 and PKCζ, were not analyzed, thus 
this is something one needs to do in order to understand if this inability to translocate GLUT4 
results from a flawed in the insulin-signaling cascade.  
If signaling pathway is normal, the impaired GLUT4 translocation can be either due to a 
mislocation of GLUT4, meaning that the transporter is not localized to de GSVs, or to some 
alteration in the mechanisms that lead to the movement and fusion of the GSVs with the plasma 
membrane. To test these possibilities it is important to co-localize GLUT4 with other GSVs 
markers or with markers of recycling endosomes (RE) which also contain GLUT4 and that are 
thought to be involved in the recycling that the transporter undergoes in the absence of insulin. 
Usually GSVs and RE are distinguished by the presence of the transferrin receptor, which is 
present in RE but not in GSVs (Zaid et al., 2008; Lamb et al., 2010). Recent studies propose 
that these two vesicles populations can also be distinguished through the content in Vesicle-
Associated Membrane Protein (VAMP) fusion proteins, it has been hypothesized that GSVs 
possess VAMP2 and RE, VAMP7 (Zaid et al., 2008). Apart from verifying if GLUT4 is in the 
GVSs it would be important to check for Golgi-localized, γ-ear-containing, Arf (ADP-
ribosylation factor)-binding protein (GGA) levels. Watson et al. (2004) observed that 
expression of a dominant-interfering GGA mutant completely blocked the insulin-stimulated 
translocation of newly synthetized GLUT4, and established GGA as an indispensable protein in 
the sorting of GLUT4 into the GSVs. Therefore, an alteration in GGA could explain the results 
obtained in this work. Previously, we referred that is important to analyze AS160, this analysis 
is important not only because AS160 is a component of the insulin signaling cascade but also 
because it regulates the movement of GSVs to the membrane. Phosphorylation of this protein is 
central for the stabilization of its targets, Rab proteins, in the GTP-bound form, which are 
thought to promote vesicles traffic (Klip, 2009; Rowland et al., 2011; Watson and Pessin, 
2006). 
Understanding the reason why cavin 1 and cavin 2 KD cells fail to deliver GLUT4 to 
the membrane is not an easy task since the link between insulin signaling cascade and GLUT4 
translocation to the membrane is not fully understood and because up to date no connection 
between cavins and GSVs trafficking has been made, thereby we think this work is the 
beginning of a journey. 
Putting all the results together we confirmed that both cavin 1 and cavin 2 localize in 
caveolae, that they are needed for caveolae formation and that cavin 1 and cavin 2 expression 
levels are dependent on each other. We concluded that cavin 1 is necessary for adipocyte 
differentiation and that both cavin 1 and cavin 2 affect GLUT4 protein levels. Finally, we 
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concluded that cavin 1 and cavin 2 are necessary for insulin-stimulated GLUT4 translocation to 
the plasma membrane and for insulin-stimulated glucose transport.  
To continue this work we aim to identify or characterize the compartments where 
GLUT4 is being held in cavin KD cells, as said above, immunolocalizing transferrin receptor 
and VAMP proteins and we also want to verify the levels of GGA and AS160 which are 
essential in the GLUT4 sorting to the GSVs and to translocate these vesicles to caveolae, 
respectively. It is also important to examine the location of caveolin-1, verifying by 
immunolocalization if caveolin-1 is present in the LDs as we hypothesized. Finally, we want to 
characterize KD cells when differentiated in low glucose medium, in an attempt to reach more 
physiological conditions. 
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